The Gemelli University Hospital is a large general hospital in Rome, Italy. With 1575 beds, it is the second-largest hospital in Italy, the largest hospital in Rome and one of the largest private hospitals in Europe.

There are 1,575 beds in Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica.

During the past decade, Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica" #1 collaborator was "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator, "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica" are "Breast Cancer" (3 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Biliary Tract Cancer" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Cholangiocarcinoma" (1 trials). Many other conditions were trialed in "Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (6 trials), "Trastuzumab" (3 trials), "Docetaxel" (2 trials), "Pertuzumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Universitario "Agostino Gemelli"; U.O.C. Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".